Teva Appoints CNS Head

Mike Derkacz has been appointed senior vice president, head of global CNS (Central Nervous System), Teva Pharmaceutical Industries. He will report to Rob Koremans, M.D., president and chief executive officer, Global Specialty Medicines. 
 
Mr. Derkacz has more than 23 years of commercial operations and management experience in the pharmaceutical industry. He joined Teva in 2011 and previously served as vice president, general manager of CNS U.S., overseeing the CNS portfolio. He has been responsible for marketing, sales, strategic planning and portfolio development, leading a team of 700, including three sales forces and six products.
 
“Mike has a strong reputation for successfully launching new products, developing strategic focus, building and leading highly effective teams and organizations, and leveraging innovative strategies to drive revenue growth,” said Dr. Koremans. “This appointment is important for Teva as we continue to focus on our core specialty areas of CNS and Respiratory and I am looking forward to Mike bringing his unique strengths to this role.”